When will Compass Pathways submit a NDA for COMP360 psilocybin?
Salute e medicinaOne-OffScienzaBusiness e aziende1m
KalshiVerifica disponibilitàKYC richiestoDati di risoluzione verificatiBen calibratoPunto medio del book selezionato
before 2027 · —
Caricamento del book selezionato…
—
Prezzo registrato
before 2027 85%In testa tra 6 esiti
before 2027 85%Qualità del mercato
31 / 100
Bassa qualitàVolume 24h
10,1 €
Open interest
11,9K USD
Open interest medioBid / Ask
— / —
before 2027Spread
—
Dati di mercato
Aggiornato 55 minuti fa
In ritardo24 mar 26, 14:00 UTC1 dic 26, 15:00 UTC
Il grafico e le variazioni mostrano probabilità storiche salvate, non il book selezionato in tempo reale.
Trend
Riga selezionata: punto medio del book. Altre righe: riferimenti salvati, eventualmente normalizzati; le variazioni a 24h usano lo storico salvato.
before SeptemberPersa
before OctoberPersa
Condizioni della piattaforma
Fonte: Kalshi
Queste condizioni sono informative; il trading simulato di CoinRithm segue regole proprie.
- Chiusura anticipata:
- Sì
- Tempo di liquidazione:
- 30m (indicativo)
Profondità di mercato · before 2027
Caricamento del book selezionato…
—
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
KalshiWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWhen will I be able to buy cultured meat at a random Whole Foods?
Manifold MarketsWill Tomorrow Bio exist or have continuity with another organisation in 20 years?
Manifold MarketsWill Eli Lilly (LLY) Q3 Zepbound sales be above __?
PolymarketWill 3 mg THC beverages be federally legal to sell?
KalshiRegole
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Regole per ogni esito
- before 2027
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- before April 2027
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
- before December
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- before November
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- before September
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- before October
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.